Comparison 6. IV prostaglandin F2 alpha vs IV oxytocin: all women.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Vaginal delivery not achieved within 24 hours	7	580	Risk Ratio (M‐H, Fixed, 95% CI)	0.87 [0.60, 1.24]
2 Uterine hyperstimulation with fetal heart rate changes	5	390	Risk Ratio (M‐H, Fixed, 95% CI)	6.76 [1.23, 37.11]
3 Caesarean section	6	572	Risk Ratio (M‐H, Fixed, 95% CI)	2.07 [0.95, 4.49]
4 Serious neonatal morbidity or perinatal death	7	580	Risk Ratio (M‐H, Fixed, 95% CI)	2.89 [0.31, 27.26]
5 Serious maternal morbidity or death	6	480	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6 Cervix unfavourable/unchanged after 12 to 24 hours	2	128	Risk Ratio (M‐H, Fixed, 95% CI)	1.29 [0.33, 5.01]
8 Uterine hyperstimulation without fetal heart rate changes	4	218	Risk Ratio (M‐H, Fixed, 95% CI)	7.5 [1.79, 31.35]
11 Instrumental vaginal delivery	2	130	Risk Ratio (M‐H, Fixed, 95% CI)	1.28 [0.73, 2.24]
13 Apgar score < 7 at 5 minutes	7	580	Risk Ratio (M‐H, Fixed, 95% CI)	1.14 [0.46, 2.86]
16 Perinatal death	6	550	Risk Ratio (M‐H, Fixed, 95% CI)	2.89 [0.31, 27.26]
18 Maternal side‐effects (all)	6	550	Risk Ratio (M‐H, Fixed, 95% CI)	2.41 [1.39, 4.18]
19 Nausea	3	372	Risk Ratio (M‐H, Fixed, 95% CI)	2.00 [0.74, 5.41]
20 Vomiting	3	422	Risk Ratio (M‐H, Fixed, 95% CI)	1.88 [0.91, 3.86]
21 Diarrhoea	2	322	Risk Ratio (M‐H, Fixed, 95% CI)	4.66 [0.23, 95.87]
22 Thrombophlebitis	3	250	Risk Ratio (M‐H, Fixed, 95% CI)	5.0 [0.88, 28.37]
23 Postpartum haemorrhage	1	50	Risk Ratio (M‐H, Fixed, 95% CI)	1.0 [0.15, 6.55]
24 Serious maternal complication	1	28	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]